MENU
QNRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Quoin Pharmaceuticals (QNRX) Earnings Date & Reports
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
QNRX is expected to report earnings to fall 1.05% to -187 cents per share on November 05
Q3'26
Est.
$-1.88
Q2'26
Beat
by $0.36
Q1'26
Beat
by $0.19
Q4'25
Missed
by $130.69
Q3'25
Missed
by $6.12
The last earnings report on August 14 showed earnings per share of -189 cents, beating the estimate of -225 cents. With 556.00 shares outstanding, the current market capitalization sits at 8.05M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
What is a Preferred Stock?
Bitcoin’s Source Code, Part 2: What Does It Mean That Bitcoin Is Open-Source?
AI Trading Bots: Top 10 Auto-Trader Long / Short, Our Brokerage, on December 10, 2024
Intelligent AI Trading Robots: Focusing on Trend Analysis and Popular Stocks (TA&FA)
What Are the Top Risk Management Strategies for Active Traders?
A.I. Advisor
published General Information
General Information
a developer of biological products for cellular therapies
Industry Biotechnology
Industry
Biotechnology
Address
42127 Pleasant Forest Court
Phone
+1 703 980-4182
Employees
6
Web
https://www.quoinpharma.com